GSK3β and MCL-1 mediate cardiomyocyte apoptosis in response to high glucose
Dongmei Su1,2, Jing Zhao3, Shanshan Hu4
1Department of Genetics, Center for Genetics, Health Department, National Research Institute for Family Planning, 12, Dahuisi Road, Haidian, Beijing, 100081, China.
Abstract:
Gestational diabetes mellitus is a risk factor for congenital heart defects. Our previous results indicated that a decrease in myocardial cells and an increase in apoptotic cells leads to heart defects under hyperglycemia, but much work remains to elucidate this important mechanism of myocardial cell apoptosis induced by high glucose (HG). In this study, we found that a decrease in GSK3β phosphorylation on Ser9 occurred concomitantly with HG-induced cardiomyocyte apoptosis and in the heart tissues of the offspring of diabetic rats in vitro and in vivo. Decreases in GSK3β (Ser9) phosphorylation in response to HG were remarkably restored after treatment with SC79, an activator of the Akt signaling pathway. SB216763, an effective inhibitor of the GSK3β signaling pathway, suppressed HG-induced apoptosis in cardiomyocytes. Further studies showed a decrease in the expression of the anti-apoptotic protein MCL-1 was associated with GSK3β-mediated apoptosis. MCL-1 overexpression partly inhibits HG-induced apoptosis in cardiomyocytes. Herein, this study revealed the roles of GSK3β and MCL-1 in modulating HG-induced cardiomyocyte apoptosis and maternal diabetes-induced abnormalities.
Insights
Gestational diabetes increases congenital heart defect risk. High glucose induces cardiomyocyte apoptosis via decreased GSK3β (Ser9) phosphorylation and MCL-1 expression, a pathway targeted by SC79.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Endocrinology
Background:
- Gestational diabetes mellitus (GDM) is a significant risk factor for congenital heart defects (CHDs).
- Hyperglycemia in GDM can lead to decreased myocardial cells and increased apoptosis, contributing to heart abnormalities.
- The precise mechanisms of high glucose-induced cardiomyocyte apoptosis remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying high glucose-induced cardiomyocyte apoptosis.
- To investigate the roles of GSK3β (glycogen synthase kinase 3 beta) and MCL-1 (myeloid cell leukemia 1) in this process.
- To explore potential therapeutic targets for maternal diabetes-induced cardiac abnormalities.
Main Methods:
- In vitro and in vivo studies using cardiomyocytes and heart tissues from diabetic rat models.
- Assessment of GSK3β phosphorylation at Ser9 in response to high glucose.
- Evaluation of the effects of SC79 (Akt pathway activator) and SB216763 (GSK3β inhibitor) on cardiomyocyte apoptosis.
- Analysis of MCL-1 expression and the impact of its overexpression.
Main Results:
- High glucose significantly decreased GSK3β phosphorylation on Ser9 in cardiomyocytes, both in vitro and in vivo.
- SC79 treatment restored GSK3β (Ser9) phosphorylation, while SB216763 exacerbated high glucose-induced apoptosis.
- A decrease in the anti-apoptotic protein MCL-1 was observed and linked to GSK3β-mediated apoptosis.
- Overexpression of MCL-1 partially protected cardiomyocytes against high glucose-induced apoptosis.
Conclusions:
- GSK3β signaling, specifically reduced phosphorylation at Ser9, plays a critical role in high glucose-induced cardiomyocyte apoptosis.
- MCL-1 acts as a downstream effector in the GSK3β-mediated apoptotic pathway.
- Targeting the GSK3β/MCL-1 axis may offer therapeutic strategies for preventing cardiac defects associated with maternal diabetes.
Related Concept Videos
Apoptosis
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine


